Integral Diagnostics Limited (ASX:IDX)
Australia · Delayed Price · Currency is AUD 2.320
-0.020 (-0.85%)
Sep 17, 2026, 4:10 PM AEST
Integral Diagnostics Market Cap
Integral Diagnostics has a market cap or net worth of 871.62 million as of September 16, 2026. Its market cap has decreased by -19.29% in one year.
Market Cap
871.62M
Enterprise Value
1.42B
Revenue
788.62M
Ranking
n/a
PE Ratio
40.35
Stock Price
2.32
ChartMarket Cap Chart
Since October 21, 2015, Integral Diagnostics's market cap has increased from 263.77M to 871.62M, an increase of 230.45%. That is a compound annual growth rate of 11.57%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2026 | 871.62M | -7.93% |
| Dec 31, 2025 | 946.69M | -12.49% |
| Dec 31, 2024 | 1.08B | 143.25% |
| Dec 29, 2023 | 444.76M | -34.84% |
| Dec 30, 2022 | 682.57M | -31.87% |
| Dec 31, 2021 | 1.00B | 16.26% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sonic Healthcare | 9.66B |
| Australian Clinical Labs | 525.53M |
| Healius | 323.14M |
| Monash IVF Group | 300.02M |
| Cryosite | 57.60M |
| Microba Life Sciences | 37.12M |
| Rhythm Biosciences | 28.31M |
| BCAL Diagnostics | 25.81M |